Position in GMAB
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$18,173,193
+$16,957,979 QoQ
Shares Held
677,346
+1616.8% QoQ
Ownership
0.110%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
18 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in GMAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Qube Research & Technologies Ltd holds $2,030,593,180 across 187 Biotechnology names. GMAB ranks #32 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
838,187 | $277,330,932 | |
| 2 | FOLD |
AMICUS THERAPEUTICS, INC.
|
8,809,340 | $127,383,056 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
3,450,904 | $95,590,040 | |
| 4 | RPRX |
Royalty Pharma plc
|
1,524,511 | $73,130,792 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
83,358 | $64,405,725 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
335,334 | $56,678,152 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
553,290 | $53,807,452 | |
| 8 | CYTK |
Cytokinetics Inc
|
779,446 | $51,373,285 |
All Filings in GMAB
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18,173,193 | 677,346 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,215,214 | 39,455 | Shares | Sole | 2026-02-17 | |
| 2025-03-31 | $2,176,434 | 111,156 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,942,767 | 236,836 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,644,227 | 313,545 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,877,962 | 114,523 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $7,117,263 | 237,956 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $8,186,573 | 257,116 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,585,346 | 130,007 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $8,721,356 | 229,449 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $10,323,697 | 273,403 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $16,489,252 | 389,081 | Shares | Sole | 2023-02-14 | |
| 2022-03-31 | $839,303 | 23,198 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $1,554,075 | 39,284 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $642,433 | 14,701 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $951,951 | 23,315 | Shares | Sole | 2021-08-13 | |
| 2020-12-31 | $1,235,372 | 30,383 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $656,197 | 17,924 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||